| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |